T. Rowe Price Associates
UTI icon

T. Rowe Price Associates’s Universal Technical Institute UTI Stock Holding History

T. Rowe Price Associates’s Portfolio UTI Stock Details UTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110M Buy
2,582,839
+882,553
+52% +$33.9M 0.01% 672
2026
Q1 		$61.4M Buy
1,700,286
+100,752
+6% +$3.18M 0.01% 723
2025
Q4 		$41.8M Buy
1,599,534
+631,070
+65% +$17.9M ﹤0.01% 859
2025
Q3 		$31.5M Buy
968,464
+931,489
+2,519% +$27.4M ﹤0.01% 937
2025
Q2 		$1.25M Sell
36,975
-2,473
-6% -$77.6K ﹤0.01% 1875
2025
Q1 		$1.01M Buy
39,448
+4,454
+13% +$120K ﹤0.01% 1951
2024
Q4 		$900K Buy
34,994
+6,163
+21% +$128K ﹤0.01% 2018
2024
Q3 		$469K Sell
28,831
-5,803
-17% -$99.5K ﹤0.01% 2276
2024
Q2 		$545K Buy
34,634
+1,259
+4% +$18.8K ﹤0.01% 2161
2024
Q1 		$532K Buy
33,375
+3,446
+12% +$50K ﹤0.01% 2187
2023
Q4 		$375K Sell
29,929
-7,726
-21% -$78.4K ﹤0.01% 2302
2023
Q3 		$316K Buy
37,655
+540
+1% +$4.2K ﹤0.01% 2312
2023
Q2 		$257K Buy
37,115
+321
+0.9% +$2.16K ﹤0.01% 2437
2023
Q1 		$272K Sell
36,794
-2,621
-7% -$18.7K ﹤0.01% 2394
2022
Q4 		$265K Buy
39,415
+208
+0.5% +$1.37K ﹤0.01% 2420
2022
Q3 		$214K Buy
39,207
+2,317
+6% +$16.2K ﹤0.01% 2520
2022
Q2 		$263K Buy
36,890
+3,090
+9% +$27.2K ﹤0.01% 2498
2022
Q1 		$299K Hold
33,800
– – ﹤0.01% 2552
2021
Q4 		$264K Hold
33,800
– – ﹤0.01% 2650
2021
Q3 		$228K Sell
33,800
-3,500
-9% -$22.8K ﹤0.01% 2677
2021
Q2 		$242K Sell
37,300
-2,198
-6% -$13K ﹤0.01% 2656
2021
Q1 		$231K Buy
39,498
+111
+0.3% +$685 ﹤0.01% 2642
2020
Q4 		$254K Hold
39,387
– – ﹤0.01% 2487
2020
Q3 		$200K Buy
39,387
+24,100
+158% +$169K ﹤0.01% 2418
2020
Q2 		$106K Sell
15,287
-26,613
-64% -$175K ﹤0.01% 2422
2020
Q1 		$249K Buy
+41,900
New +$297K ﹤0.01% 2250
2015
Q4 		– Sell
-602,200
Closed -$2.11M – 2540
2015
Q3 		$2.11M Buy
602,200
+75,000
+14% +$420K ﹤0.01% 1539
2015
Q2 		$4.53M Hold
527,200
– – ﹤0.01% 1500
2015
Q1 		$5.06M Buy
527,200
+211,600
+67% +$1.97M ﹤0.01% 1470
2014
Q4 		$3.11M Buy
+315,600
New +$3.32M ﹤0.01% 1524

Other funds holding UTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
PP
Praetorian PR Rincon, Puerto Rico $314M AUM 48.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates's UTI Position: Q2 2026 in Review

T. Rowe Price Associates increased its Universal Technical Institute (UTI) stake by 52% in Q2 2026, buying an estimated $33.9M and bringing the position to 2,582,839 shares worth $110M. The position accounts for 0.01% of the portfolio, ranked #672.

T. Rowe Price Associates first reported a position in UTI in Q4 2014 and has held it in 30 quarters since. 263 funds tracked by Wall St. Rank hold UTI as of Q2 2026.

  • T. Rowe Price Associates held 2,582,839 shares of Universal Technical Institute worth $110M as of Q2 2026.
  • T. Rowe Price Associates bought 882,553 Universal Technical Institute shares in Q2 2026, an estimated $33.9M.
  • Universal Technical Institute made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #672 holding.
  • T. Rowe Price Associates first reported a position in Universal Technical Institute in Q4 2014 and has held it in 30 quarters since.
  • 263 funds tracked by Wall St. Rank held Universal Technical Institute as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.